FDA Inspection 1316902 — InvaPharm, Inc.

InvaPharm, Inc. — FEI 3018161321

The FDA completed an inspection of InvaPharm, Inc. on May 13, 2026 in Ontario, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 13, 2026
Fiscal Year
2026
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Ontario, CA (United States)

Citations

IDCFRDescription
1573221 CFR 111.365(a)Conditions, controls -protect; microorganisms, contamination